Appraisal and Funding of Cancer Drugs from July 2016 ...

drugs with an Early Access to Medicines Scheme [EAMS] designation), at which point the drug will no longer be subject to the expenditure control mechanism. 17. For those drug/indications that receive a recommendation for use within the CDF, interim funding will also be available to pharmaceutical companies ,

  Drug, Access, Medicine, Early, Schemes, Appraisal, Emas, Cancer, Funding, Early access to medicines scheme, Appraisal and funding of cancer drugs